Yayın: Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study
| dc.contributor.author | Yurdaydın, Cihan | |
| dc.contributor.author | Wedemeyer, Heiner | |
| dc.contributor.author | Caruntu, Florin A. | |
| dc.contributor.author | Curescu, Manuela G. | |
| dc.contributor.author | Yalçın, Kendal | |
| dc.contributor.author | Akarca, Ulus S. | |
| dc.contributor.author | Zeuzem, Stefan | |
| dc.contributor.author | Erhardt, Andreas | |
| dc.contributor.author | Lueth, Stefan | |
| dc.contributor.author | Papatheodoridis, George V. | |
| dc.contributor.author | Port, Kerstin | |
| dc.contributor.author | Keskin, Onur | |
| dc.contributor.author | Radu, Monica N. | |
| dc.contributor.author | Çelen, Mustafa K. | |
| dc.contributor.author | İdilman, Ramazan | |
| dc.contributor.author | Stift, Judith | |
| dc.contributor.author | Mederacke, Ingmar | |
| dc.contributor.author | Heidrich, Benjamin | |
| dc.contributor.author | Manns, Michael P. | |
| dc.contributor.author | Dienes, Hans Peter | |
| dc.contributor.buuauthor | Gürel, Selim | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | İç Hastalıkları Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0002-7279-2161 | |
| dc.contributor.researcherid | EYK-5719-2022 | |
| dc.date.accessioned | 2022-09-29T07:33:02Z | |
| dc.date.available | 2022-09-29T07:33:02Z | |
| dc.date.issued | 2012-10 | |
| dc.description | Bu çalışma, 9-13 Kasım 2012 tarihleri arasında Boston[ABD]'da düzenlenen 63. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)'de bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | Amer Association of Study Liver Diseases | |
| dc.identifier.citation | Yurdaydın, C. vd. (2012). "Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study". Hepatology, 56, Supplement 1, 202A-203A. | |
| dc.identifier.endpage | 203A | |
| dc.identifier.issn | 0270-9139 | |
| dc.identifier.issue | Supplement 1 | |
| dc.identifier.startpage | 202A | |
| dc.identifier.uri | https://aasldpubs.onlinelibrary.wiley.com/loi/15273350/year/2012 | |
| dc.identifier.uri | http://hdl.handle.net/11452/28877 | |
| dc.identifier.volume | 56 | |
| dc.identifier.wos | 000310955601024 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.collaboration | Yurt içi | |
| dc.relation.collaboration | Yurt dışı | |
| dc.relation.collaboration | Sanayi | |
| dc.relation.journal | Hepatology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Gastroenterology & hepatology | |
| dc.subject.wos | Gastroenterology & hepatology | |
| dc.title | Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dc.wos.quartile | Q1 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/İç Hastalıkları Ana Bilim Dalı | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
